Sutro Biopharma (STRO) Net Margin Growth (3y) (2020 - 2025)
Sutro Biopharma (STRO) Net Margin Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | -30,766.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -30,766.00 |
| Sep 30, 2025 | -50,908.00 |
| Jun 30, 2025 | 7,454.00 |
| Mar 31, 2025 | 27,455.00 |
| Dec 31, 2024 | -13,134.00 |
| Sep 30, 2024 | -20,979.00 |
| Jun 30, 2024 | -16,486.00 |
| Mar 31, 2024 | -31,334.00 |
| Dec 31, 2023 | 33,886.00 |
| Sep 30, 2023 | -1,391.00 |
| Jun 30, 2023 | -16,947.00 |
| Mar 31, 2023 | -12,092.00 |
| Dec 31, 2022 | -24,666.00 |
| Sep 30, 2022 | 2,768.00 |
| Jun 30, 2022 | 5,015.00 |
| Mar 31, 2022 | -49,808.00 |
| Dec 31, 2021 | -35,002.00 |
| Sep 30, 2021 | -13,072.00 |
| Jun 30, 2021 | 18,040.00 |
| Mar 31, 2021 | 7,406.00 |